The Governance Gap: Democratizing Drug Development Through Decision Architecture.

Rayner CR; Martin NE; Smith D; Kruger E; Kirkpatrick CMJ; Pillai GC; Moore K; Nix D; Donini C; Cramer JP; Muniz E; Muniz N; Bos E; McNair D; Bhaskaran S; Sullivan M; Hartman D

doi:10.1002/cpt.70476

The Governance Gap: Democratizing Drug Development Through Decision Architecture.

Rayner CR Martin NE Smith D Kruger E Kirkpatrick CMJ Pillai GC Moore K Nix D Donini C Cramer JP Muniz E Muniz N Bos E McNair D Bhaskaran S Sullivan M Hartman D

Journal: Clinical pharmacology and therapeutics • 2026 Sep 6

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

# Biomedical Sciences # Life Sciences # Medicine

How to Cite this Article

                    Rayner CR, Martin NE, Smith D, et al. (2026). "The Governance Gap: Democratizing Drug Development Through Decision Architecture.". Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70476                

Access Full Article

Read Original Article ↗ View Source PDF ↗

MainReads is an independent discovery directory. Clicking above directs you to the official publisher repository.

Licence & Open Access

PMC Public Access (View-Only)

Publicly accessible via the publisher or archive. Commercial redistribution or automated full-text duplication without author permission may be restricted.

Identifiers & Provenance

DOI: 10.1002/cpt.70476 ↗
PMCID: PMC13547536 ↗
PMID: 42702743 ↗
Primary Index: PMC